This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Rethinking Progress in Clinical Trials
Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development
05/20/2026
9 min read
